Evofem Biosciences Reports Fourth Quarter and Year-End 2021 Financial Results and Provides Corporate Update

SAN DIEGO, March 3, 2022 /PRNewswire/ — Evofem Biosciences, Inc. (Nasdaq: EVFM), a commercial stage biopharmaceutical company, today reported financial results for the three- and twelve-month periods ended December 31, 2021. "In our first full year as a commercial company Evofem…

Click here to view original post